Ledger.Open graph →
SEC Form D · filed October 16, 2018

Qpex Biopharma, Inc

Offering
$33.1M
Sold
$22.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN DIEGO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Kevin N. Li · San Diego, CADirectorCarol N. Gallagher · San Diego, CADirectorDouglas N. Reed · San Diego, CADirectorDaniel N. Burgess · San Diego, CADirectorTerry N. Gould · San Diego, CADirectorMichael N. Dudley · San Diego, CAExec · DirectorMark Heising · San Francisco, CADirectorDarryl Smith · ROCKWALL, TXExec · DirectorWilliam Jennings · Pasadena, CADirectorBrian Lucia · ROCKWALL, TXDirectorGreg Martin · ROCKWALL, TXDirectorShahid Khan · San Francisco, CADirectorHeather Atkinson · Colorado Springs, CODirectorRudy Touzet · Miami, FLDirectorSean Ma · Hong Kong, Hong KongDirectorAdam Waterous · Banff, Alberta, CanadaDirectorJed Walsh · DALLAS, TXDirectorEnlightenment CoInvest GP, LLC · Chevy Chase, MDExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗